A dual ApoC-II mimetic - ApoC-III antagonist peptide as a potential treatment for hypertriglyceridemia. (August 2021) - Wolska, A.; Sviridov, D.; Pourmousa, M.; Pastor, R.; Pryor, M.; Wilson, S.; Lo, L.; Ghosh, S.; Davidson, M.; Devalaraja, M.; Goldberg, I.; Basu, D.; et al.